A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study
Public ClinicalTrials.gov record NCT03687827. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Cross-over, Open-label, Multi-centre Trial Comparing the Effect of Insulin Degludec and Insulin Glargine 100U/mL, With or Without OADs in Subjects With Type 2 Diabetes Using Flash Glucose Monitoring
Study identification
- NCT ID
- NCT03687827
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Enrollment
- 498 participants
Conditions and interventions
Conditions
Interventions
- Insulin degludec Drug
- Insulin glargine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 1, 2018
- Primary completion
- Dec 19, 2019
- Completion
- Dec 26, 2019
- Last update posted
- Jan 11, 2021
2018 – 2019
United States locations
- U.S. sites
- 34
- U.S. states
- 16
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Chandler | Arizona | 85224 | — |
| Novo Nordisk Investigational Site | Tucson | Arizona | 85741 | — |
| Novo Nordisk Investigational Site | Fresno | California | 93720 | — |
| Novo Nordisk Investigational Site | Lancaster | California | 93534 | — |
| Novo Nordisk Investigational Site | Northridge | California | 91325 | — |
| Novo Nordisk Investigational Site | Poway | California | 92064 | — |
| Novo Nordisk Investigational Site | Van Nuys | California | 91405 | — |
| Novo Nordisk Investigational Site | Hamden | Connecticut | 06517 | — |
| Novo Nordisk Investigational Site | Bradenton | Florida | 34201 | — |
| Novo Nordisk Investigational Site | Cooper City | Florida | 33024 | — |
| Novo Nordisk Investigational Site | Hollywood | Florida | 33024 | — |
| Novo Nordisk Investigational Site | New Port Richey | Florida | 34652 | — |
| Novo Nordisk Investigational Site | Orlando | Florida | 32825 | — |
| Novo Nordisk Investigational Site | Pembroke Pines | Florida | 33027 | — |
| Novo Nordisk Investigational Site | Skokie | Illinois | 60077 | — |
| Novo Nordisk Investigational Site | Topeka | Kansas | 66606 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40503 | — |
| Novo Nordisk Investigational Site | Louisville | Kentucky | 40213 | — |
| Novo Nordisk Investigational Site | Boston | Massachusetts | 02115-5804 | — |
| Novo Nordisk Investigational Site | Boston | Massachusetts | 02118 | — |
| Novo Nordisk Investigational Site | Kalispell | Montana | 59901 | — |
| Novo Nordisk Investigational Site | New Windsor | New York | 12553 | — |
| Novo Nordisk Investigational Site | Greenville | North Carolina | 27834 | — |
| Novo Nordisk Investigational Site | Statesville | North Carolina | 28625 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45245 | — |
| Novo Nordisk Investigational Site | Toledo | Ohio | 43614 | — |
| Novo Nordisk Investigational Site | Pelzer | South Carolina | 29669 | — |
| Novo Nordisk Investigational Site | Dakota Dunes | South Dakota | 57049 | — |
| Novo Nordisk Investigational Site | Nashville | Tennessee | 37203 | — |
| Novo Nordisk Investigational Site | Amarillo | Texas | 79106 | — |
| Novo Nordisk Investigational Site | Kerrville | Texas | 78028 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78215 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78224 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78228-6205 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03687827, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 11, 2021 · Synced May 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03687827 live on ClinicalTrials.gov.